Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study
Nocturia impairs quality of life (QoL). We have performed a non-interventional study in which men with lower urinary tract symptoms (LUTS) were treated for at least 3 months with tamsulosin oral controlled absorption system (0.4 mg q.d.). Other than observing efficacy and tolerability of this drug f...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00816/full |
id |
doaj-65c6f4a598e64122ab11ca4b987c8e1c |
---|---|
record_format |
Article |
spelling |
doaj-65c6f4a598e64122ab11ca4b987c8e1c2020-11-25T03:22:05ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-06-011110.3389/fphar.2020.00816527516Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional StudyMartin C. Michel0Helmut Schumacher1Ludwig Mehlburger2Jean J.M.C.H. de la Rosette3Department of Pharmacology, Johannes Gutenberg University, Mainz, GermanyConsultant, Ingelheim, GermanyDepartment of Medical Affairs, Boehringer Ingelheim, Ingelheim, GermanyDepartment of Urology, Istanbul Medipol University, Istanbul, TurkeyNocturia impairs quality of life (QoL). We have performed a non-interventional study in which men with lower urinary tract symptoms (LUTS) were treated for at least 3 months with tamsulosin oral controlled absorption system (0.4 mg q.d.). Other than observing efficacy and tolerability of this drug formulation, the study was designed to explore the relative roles of number of nocturia episodes and of non-urological causes of nocturia on nocturia-related QoL at baseline and treatment-associated changes thereof. The study enrolled 5775 men seeking treatment of their LUTS. Tamsulosin improved LUTS, e.g. International Prostate Symptom Score from 19.5 ± 5.9 to 10.1 ± 4.9 (means ± SD). This was associated by clinically meaningful improvements in the Nocturia QoL score (from 45 ± 19 to 73 ± 17 points) and other QoL scores. Number of nocturnal voids was the key driver of all QoL scores at baseline; change of number of nocturia episodes that of improvement of all QoL scores upon treatment. In contrast, non-urological causes of nocturia such as heart failure, diabetes, sleep apnea, fluid or alcohol intake or use of diuretics or hypnotics had only small if any effects on baseline QoL or treatment-associated improvements thereof. The observed effects of non-urological causes on QoL apparently were largely driven by their effect on number of nocturnal voids. These data further support the idea that improvement of nocturia may be an important treatment goal in male LUTS.https://www.frontiersin.org/article/10.3389/fphar.2020.00816/fullmale lower urinary tract symptomsnocturiaquality of lifediabetesheart failure |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Martin C. Michel Helmut Schumacher Ludwig Mehlburger Jean J.M.C.H. de la Rosette |
spellingShingle |
Martin C. Michel Helmut Schumacher Ludwig Mehlburger Jean J.M.C.H. de la Rosette Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study Frontiers in Pharmacology male lower urinary tract symptoms nocturia quality of life diabetes heart failure |
author_facet |
Martin C. Michel Helmut Schumacher Ludwig Mehlburger Jean J.M.C.H. de la Rosette |
author_sort |
Martin C. Michel |
title |
Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study |
title_short |
Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study |
title_full |
Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study |
title_fullStr |
Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study |
title_full_unstemmed |
Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study |
title_sort |
factors associated with nocturia-related quality of life in men with lower urinary tract symptoms and treated with tamsulosin oral controlled absorption system in a non-interventional study |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2020-06-01 |
description |
Nocturia impairs quality of life (QoL). We have performed a non-interventional study in which men with lower urinary tract symptoms (LUTS) were treated for at least 3 months with tamsulosin oral controlled absorption system (0.4 mg q.d.). Other than observing efficacy and tolerability of this drug formulation, the study was designed to explore the relative roles of number of nocturia episodes and of non-urological causes of nocturia on nocturia-related QoL at baseline and treatment-associated changes thereof. The study enrolled 5775 men seeking treatment of their LUTS. Tamsulosin improved LUTS, e.g. International Prostate Symptom Score from 19.5 ± 5.9 to 10.1 ± 4.9 (means ± SD). This was associated by clinically meaningful improvements in the Nocturia QoL score (from 45 ± 19 to 73 ± 17 points) and other QoL scores. Number of nocturnal voids was the key driver of all QoL scores at baseline; change of number of nocturia episodes that of improvement of all QoL scores upon treatment. In contrast, non-urological causes of nocturia such as heart failure, diabetes, sleep apnea, fluid or alcohol intake or use of diuretics or hypnotics had only small if any effects on baseline QoL or treatment-associated improvements thereof. The observed effects of non-urological causes on QoL apparently were largely driven by their effect on number of nocturnal voids. These data further support the idea that improvement of nocturia may be an important treatment goal in male LUTS. |
topic |
male lower urinary tract symptoms nocturia quality of life diabetes heart failure |
url |
https://www.frontiersin.org/article/10.3389/fphar.2020.00816/full |
work_keys_str_mv |
AT martincmichel factorsassociatedwithnocturiarelatedqualityoflifeinmenwithlowerurinarytractsymptomsandtreatedwithtamsulosinoralcontrolledabsorptionsysteminanoninterventionalstudy AT helmutschumacher factorsassociatedwithnocturiarelatedqualityoflifeinmenwithlowerurinarytractsymptomsandtreatedwithtamsulosinoralcontrolledabsorptionsysteminanoninterventionalstudy AT ludwigmehlburger factorsassociatedwithnocturiarelatedqualityoflifeinmenwithlowerurinarytractsymptomsandtreatedwithtamsulosinoralcontrolledabsorptionsysteminanoninterventionalstudy AT jeanjmchdelarosette factorsassociatedwithnocturiarelatedqualityoflifeinmenwithlowerurinarytractsymptomsandtreatedwithtamsulosinoralcontrolledabsorptionsysteminanoninterventionalstudy |
_version_ |
1724611286100082688 |